These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29966324)

  • 1. The Use of Antidepressive Agents and Bone Mineral Density in Women: A Meta-Analysis.
    Schweiger JU; Schweiger U; Hüppe M; Kahl KG; Greggersen W; Jauch-Chara K; Fassbinder E
    Int J Environ Res Public Health; 2018 Jun; 15(7):. PubMed ID: 29966324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates of bone loss among women initiating antidepressant medication use in midlife.
    Diem SJ; Ruppert K; Cauley JA; Lian Y; Bromberger JT; Finkelstein JS; Greendale GA; Solomon DH
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4355-63. PubMed ID: 24001746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures.
    Diem SJ; Blackwell TL; Stone KL; Yaffe K; Haney EM; Bliziotes MM; Ensrud KE
    Arch Intern Med; 2007 Jun; 167(12):1240-5. PubMed ID: 17592096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
    Zhou C; Fang L; Chen Y; Zhong J; Wang H; Xie P
    Osteoporos Int; 2018 Jun; 29(6):1243-1251. PubMed ID: 29435621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
    Haney EM; Chan BK; Diem SJ; Ensrud KE; Cauley JA; Barrett-Connor E; Orwoll E; Bliziotes MM;
    Arch Intern Med; 2007 Jun; 167(12):1246-51. PubMed ID: 17592097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study.
    Feuer AJ; Demmer RT; Thai A; Vogiatzi MG
    Bone; 2015 Sep; 78():28-33. PubMed ID: 25940460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone density and depressive disorder: a meta-analysis.
    Schweiger JU; Schweiger U; Hüppe M; Kahl KG; Greggersen W; Fassbinder E
    Brain Behav; 2016 Aug; 6(8):e00489. PubMed ID: 27547495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bones of Contention: A Comprehensive Literature Review of Non-SSRI Antidepressant Use and Bone Health.
    Power C; Duffy R; Mahon J; McCarroll K; Lawlor BA
    J Geriatr Psychiatry Neurol; 2020 Nov; 33(6):340-352. PubMed ID: 31665962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of mental disorders and psychotropic medications with bone texture as measured with trabecular bone score.
    Hafizi S; Lix LM; Hans D; Bolton JM; Leslie WD
    Bone; 2022 Dec; 165():116565. PubMed ID: 36152942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Selective Serotonin Reuptake Inhibitors and Bone Mineral Density in Elderly Women.
    Saraykar S; John V; Cao B; Hnatow M; Ambrose CG; Rianon N
    J Clin Densitom; 2018; 21(2):193-199. PubMed ID: 28712980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antidepressants on postmenopausal bone loss - A 5-year longitudinal study from the OSTPRE cohort.
    Rauma PH; Honkanen RJ; Williams LJ; Tuppurainen MT; Kröger HP; Koivumaa-Honkanen H
    Bone; 2016 Aug; 89():25-31. PubMed ID: 27179631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.
    Ziere G; Dieleman JP; van der Cammen TJ; Hofman A; Pols HA; Stricker BH
    J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
    Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
    Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients.
    Arbouw ME; Movig KL; Neef C; Guchelaar HJ; Egberts TC
    Eur J Clin Pharmacol; 2007 Feb; 63(2):181-7. PubMed ID: 17200834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adverse skeletal effects of selective serotonin reuptake inhibitors.
    Tsapakis EM; Gamie Z; Tran GT; Adshead S; Lampard A; Mantalaris A; Tsiridis E
    Eur Psychiatry; 2012 Apr; 27(3):156-69. PubMed ID: 21295451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the use of SSRIs reduce medical care utilization and expenditures?
    Chung S
    J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in adolescents with eating disorders exposed to selective serotonin reuptake inhibitors.
    Couturier J; Sy A; Johnson N; Findlay S
    Eat Disord; 2013; 21(3):238-48. PubMed ID: 23600554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight outcomes among antidepressant users in nursing facilities.
    Rigler SK; Webb MJ; Redford L; Brown EF; Zhou J; Wallace D
    J Am Geriatr Soc; 2001 Jan; 49(1):49-55. PubMed ID: 11207842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
    Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
    Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
    Anderson IM
    J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.